▟ Vinebot intrinsic value, daily

← back

SCHW Charles Schwab Corporation

capital_markets · valued with opus medium conviction · deep-dived 2026-11-19

SELL
Intrinsic value$46.24
Price (at call)$92.56
Margin of safety -50.0%
vs market (rating basis) -41.2%

Elite franchise, but even a 22% normalized ROE leaves 3.7x book pricing in peak-cycle earnings.

The story

Schwab has the dominant US retail brokerage and wealth franchise, with over $10T in client assets, scale-driven cost leadership and cheap sweep deposits that fund a large securities book. Trailing ROE of about 25% reflects strong net interest margin recovery, high trading activity and a book still depressed by AOCI losses, so it overstates through-the-cycle returns. The balance sheet is liquid and mostly government-backed, but the 2023 deposit-sorting episode showed its rate and duration sensitivity. The business is near a cyclical earnings peak, with rate cuts and margin compression the main downside.

Normalized ROE moves up modestly from 21% to 22% because revenue rose to $27.1B and trailing ROE held near 25%, which suggests more durable fee and NII earning power. It stays well below trailing because AOCI accretion will rebuild book and rate cuts will compress sweep spreads. Book growth stays at 7% (buybacks offset retention) and fades to 4%, below the 4.3% risk-free rate. Beta matches the 1.1 industry anchor.

Value drivers

Return on equity (normalized)22.0%
Book-value growth (Y1)7.0%
Terminal book growth4.0%
Beta1.10
Failure probability1.0%
Cost of equity9.2%

Valuation bridge

PV of excess returns26.49B
PV of terminal excess11.46B
Equity value79.80B
÷ shares → per share$46.24

Projected excess returns on equity

YrBook equityROEExcess returnPV
142.66B 22.0%5.44B 4.98B
245.65B 20.8%5.27B 4.42B
348.69B 19.6%5.04B 3.87B
451.78B 18.4%4.75B 3.33B
554.88B 17.2%4.38B 2.81B
657.99B 16.0%3.93B 2.31B
761.08B 14.8%3.41B 1.84B
864.14B 13.6%2.81B 1.39B
967.13B 12.4%2.14B 967.24M
1070.04B 11.2%1.40B 578.32M

Key risks

  • Fed rate cuts compress net interest margin and sweep economics
  • Renewed cash sorting into higher-yield products forces costly funding
  • Equity market drawdown cuts trading volumes, asset-based fees and margin balances

Catalysts

  • AOCI accretion and capital return through buybacks as securities mature
  • Faster-than-expected net new asset growth and wealth-advice fee mix shift

History

DatePriceIntrinsicMoSRating
2026-11-19$92.56 $46.24 -50.0% SELL
2026-10-26$90.58 $42.94 -52.6% SELL
2026-09-30$99.10 $41.17 -58.5% SELL
2026-09-04$110.38 $40.10 -63.7% SELL
2026-08-11$107.99 $40.30 -62.7% SELL
2026-07-15$101.10 $35.07 -65.3% SELL
2026-06-23$93.17 $35.40 -62.0% SELL